Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Ipca Laboratories Ltd.
NSE: IPCALAB
|
BSE: 524494
|
ISIN: INE571A01038
|
Industry: Pharmaceuticals
|
Strong Performer, Getting Expensive
1507.8000
-20.00
(
-1.31
%)
NSE
Jan 13, 2026
15:31 PM
29.07% Gain from 52W Low
Volume:
147.0K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Ipca Laboratories Ltd.
12 Aug 2023
1507.80
-1.31%
Domestic formulation drives earnings
Neutral:
Ipca Laboratories Ltd.
by
Motilal Oswal
Target: 840
Target
Motilal Oswal
Number of FII/FPI investors decreased from 270 to 254 in Sep 2025 qtr
More from Ipca Laboratories Ltd.
Recommended
Market closes lower, dragged down by foreign investor outflows and mixed earnings
Trendlyne Marketwatch |
13 Jan 2026
IPO wave continues as Amagi Media and Five SMEs open for subscription
|
12 Jan 2026
IPCA Labs’ domestic formulations business to drive growth
|
05 Jul 2021